Logo image of AKO.B

EMBOTELLADORA ANDINA-ADR B (AKO.B) Stock Fundamental Analysis

NYSE:AKO.B - New York Stock Exchange, Inc. - US29081P3038 - ADR - Currency: USD

23.2  +0.28 (+1.22%)

After market: 23.2 0 (0%)

Fundamental Rating

4

AKO.B gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. There are concerns on the financial health of AKO.B while its profitability can be described as average. While showing a medium growth rate, AKO.B is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

Each year in the past 5 years AKO.B has been profitable.
Each year in the past 5 years AKO.B had a positive operating cash flow.
AKO.B Yearly Net Income VS EBIT VS OCF VS FCFAKO.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

1.2 Ratios

AKO.B has a Return On Assets of 7.87%. This is in the better half of the industry: AKO.B outperforms 71.88% of its industry peers.
AKO.B has a Return On Equity of 23.72%. This is amongst the best in the industry. AKO.B outperforms 84.38% of its industry peers.
AKO.B has a Return On Invested Capital (11.03%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AKO.B is in line with the industry average of 11.51%.
The 3 year average ROIC (10.65%) for AKO.B is below the current ROIC(11.03%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.87%
ROE 23.72%
ROIC 11.03%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)19.28%
ROE(5y)17.45%
ROIC(3y)10.65%
ROIC(5y)9.4%
AKO.B Yearly ROA, ROE, ROICAKO.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKO.B has a Profit Margin (5.97%) which is comparable to the rest of the industry.
AKO.B's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 10.08%, AKO.B perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
In the last couple of years the Operating Margin of AKO.B has declined.
AKO.B has a Gross Margin of 39.80%. This is in the lower half of the industry: AKO.B underperforms 65.63% of its industry peers.
AKO.B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.08%
PM (TTM) 5.97%
GM 39.8%
OM growth 3Y-0.37%
OM growth 5Y-2.84%
PM growth 3Y1.12%
PM growth 5Y-5.87%
GM growth 3Y1.48%
GM growth 5Y-0.7%
AKO.B Yearly Profit, Operating, Gross MarginsAKO.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, AKO.B has about the same amount of shares outstanding.
AKO.B has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for AKO.B has been reduced compared to a year ago.
AKO.B Yearly Shares OutstandingAKO.B Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AKO.B Yearly Total Debt VS Total AssetsAKO.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

The Debt to FCF ratio of AKO.B is 12.45, which is on the high side as it means it would take AKO.B, 12.45 years of fcf income to pay off all of its debts.
AKO.B's Debt to FCF ratio of 12.45 is in line compared to the rest of the industry. AKO.B outperforms 40.63% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that AKO.B is somewhat dependend on debt financing.
AKO.B has a Debt to Equity ratio of 0.98. This is in the lower half of the industry: AKO.B underperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 12.45
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
AKO.B Yearly LT Debt VS Equity VS FCFAKO.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.3 Liquidity

AKO.B has a Current Ratio of 1.28. This is a normal value and indicates that AKO.B is financially healthy and should not expect problems in meeting its short term obligations.
AKO.B's Current ratio of 1.28 is in line compared to the rest of the industry. AKO.B outperforms 53.13% of its industry peers.
A Quick Ratio of 0.82 indicates that AKO.B may have some problems paying its short term obligations.
AKO.B has a Quick ratio of 0.82. This is comparable to the rest of the industry: AKO.B outperforms 56.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.82
AKO.B Yearly Current Assets VS Current LiabilitesAKO.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.41% over the past year.
The Earnings Per Share has been growing slightly by 5.30% on average over the past years.
Looking at the last year, AKO.B shows a very strong growth in Revenue. The Revenue has grown by 23.14%.
The Revenue has been growing by 12.63% on average over the past years. This is quite good.
EPS 1Y (TTM)16.41%
EPS 3Y16.59%
EPS 5Y5.3%
EPS Q2Q%51.15%
Revenue 1Y (TTM)23.14%
Revenue growth 3Y13.3%
Revenue growth 5Y12.63%
Sales Q2Q%9.81%

3.2 Future

Based on estimates for the next years, AKO.B will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.13% on average per year.
Based on estimates for the next years, AKO.B will show a quite strong growth in Revenue. The Revenue will grow by 8.04% on average per year.
EPS Next Y10.02%
EPS Next 2Y8.65%
EPS Next 3Y8.13%
EPS Next 5YN/A
Revenue Next Year12.06%
Revenue Next 2Y8.74%
Revenue Next 3Y8.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKO.B Yearly Revenue VS EstimatesAKO.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1T 2T 3T
AKO.B Yearly EPS VS EstimatesAKO.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100 200 300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
AKO.B Price Earnings VS Forward Price EarningsAKO.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKO.B Per share dataAKO.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.65%
EPS Next 3Y8.13%

More info and screens

0

5. Dividend

5.1 Amount

AKO.B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMBOTELLADORA ANDINA-ADR B

NYSE:AKO.B (8/1/2025, 8:19:57 PM)

After market: 23.2 0 (0%)

23.2

+0.28 (+1.22%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27
Inst Owners62.38%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.96B
Analysts75.56
Price Target26.24 (13.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)12.91%
DP108.67%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-24 2025-01-24 (0.957762)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.94%
Min EPS beat(2)4.27%
Max EPS beat(2)11.61%
EPS beat(4)2
Avg EPS beat(4)-0.43%
Min EPS beat(4)-14.53%
Max EPS beat(4)11.61%
EPS beat(8)4
Avg EPS beat(8)5.99%
EPS beat(12)6
Avg EPS beat(12)1.8%
EPS beat(16)8
Avg EPS beat(16)-1.74%
Revenue beat(2)1
Avg Revenue beat(2)2.85%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.98%
Revenue beat(4)2
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)6.98%
Revenue beat(8)4
Avg Revenue beat(8)-1.4%
Revenue beat(12)6
Avg Revenue beat(12)10.55%
Revenue beat(16)10
Avg Revenue beat(16)20.56%
PT rev (1m)-0.06%
PT rev (3m)9.87%
EPS NQ rev (1m)-13.18%
EPS NQ rev (3m)-9.51%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)3.45%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.87%
ROE 23.72%
ROCE 16.87%
ROIC 11.03%
ROICexc 12.05%
ROICexgc 19.14%
OM 10.08%
PM (TTM) 5.97%
GM 39.8%
FCFM 2.13%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)19.28%
ROE(5y)17.45%
ROIC(3y)10.65%
ROIC(5y)9.4%
ROICexc(3y)12.72%
ROICexc(5y)11.46%
ROICexgc(3y)22.87%
ROICexgc(5y)20.31%
ROCE(3y)16.29%
ROCE(5y)14.39%
ROICexcg growth 3Y10.2%
ROICexcg growth 5Y5.6%
ROICexc growth 3Y10.16%
ROICexc growth 5Y6.74%
OM growth 3Y-0.37%
OM growth 5Y-2.84%
PM growth 3Y1.12%
PM growth 5Y-5.87%
GM growth 3Y1.48%
GM growth 5Y-0.7%
F-Score7
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 12.45
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.13%
Interest Coverage -6.1
Cash Conversion N/A
Profit Quality 35.76%
Current Ratio 1.28
Quick Ratio 0.82
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.81%
Cap/Sales(5y)7%
Profit Quality(3y)89.87%
Profit Quality(5y)105.14%
High Growth Momentum
Growth
EPS 1Y (TTM)16.41%
EPS 3Y16.59%
EPS 5Y5.3%
EPS Q2Q%51.15%
EPS Next Y10.02%
EPS Next 2Y8.65%
EPS Next 3Y8.13%
EPS Next 5YN/A
Revenue 1Y (TTM)23.14%
Revenue growth 3Y13.3%
Revenue growth 5Y12.63%
Sales Q2Q%9.81%
Revenue Next Year12.06%
Revenue Next 2Y8.74%
Revenue Next 3Y8.04%
Revenue Next 5YN/A
EBIT growth 1Y17.07%
EBIT growth 3Y12.89%
EBIT growth 5Y9.43%
EBIT Next Year50.95%
EBIT Next 3Y18.94%
EBIT Next 5YN/A
FCF growth 1Y-43.6%
FCF growth 3Y-31.39%
FCF growth 5Y-18.84%
OCF growth 1Y6.6%
OCF growth 3Y4.55%
OCF growth 5Y6.17%